Leveraging AI to help analyze and visualize data gathered from a variety of data sets enables data-driven insights and fast analysis without the high costs of talent and technology. In today's ...

Overall response rate of 40% consistent across sarcoma indications; median duration of response ~11 months with patients still in response at time of analysis Interim analysis data reinforces the ...

Jaguar Health’s (JAGX) Napo Pharmaceuticals announced that the data from the recently conducted analysis of the prespecified subgroup of adult patients with breast cancer from the Phase 3 OnTarget ...